322 related articles for article (PubMed ID: 25875842)
1. Molecular diagnosis of Fragile X syndrome in subjects with intellectual disability of unknown origin: implications of its prevalence in regional Pakistan.
Kanwal M; Alyas S; Afzal M; Mansoor A; Abbasi R; Tassone F; Malik S; Mazhar K
PLoS One; 2015; 10(4):e0122213. PubMed ID: 25875842
[TBL] [Abstract][Full Text] [Related]
2. Frequency of FMR1 gene mutation and CGG repeat polymorphism in intellectually disabled children in Pakistan.
Fatima T; Zaidi SA; Sarfraz N; Perween S; Khurshid F; Imtiaz F
Am J Med Genet A; 2014 May; 164A(5):1151-61. PubMed ID: 24478267
[TBL] [Abstract][Full Text] [Related]
3. Molecular diagnosis of fragile X syndrome using methylation sensitive techniques in a cohort of patients with intellectual disability.
Chaudhary AG; Hussein IR; Abuzenadah A; Gari M; Bassiouni R; Sogaty S; Lary S; Al-Quaiti M; Al Balwi M; Al Qahtani M
Pediatr Neurol; 2014 Apr; 50(4):368-76. PubMed ID: 24630283
[TBL] [Abstract][Full Text] [Related]
4. Unraveling unusual X-chromosome patterns during fragile-X syndrome genetic testing.
Esposito G; Tremolaterra MR; Savarese M; Spiniello M; Patrizio MP; Lombardo B; Pastore L; Salvatore F; Carsana A
Clin Chim Acta; 2018 Jan; 476():167-172. PubMed ID: 29170104
[TBL] [Abstract][Full Text] [Related]
5. FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile.
Santa María L; Aliaga S; Faundes V; Morales P; Pugin Á; Curotto B; Soto P; Peña MI; Salas I; Alliende MA
Genet Res (Camb); 2016 Jun; 98():e11. PubMed ID: 27350105
[TBL] [Abstract][Full Text] [Related]
6. Fragile X syndrome screening in Chinese children with unknown intellectual developmental disorder.
Chen X; Wang J; Xie H; Zhou W; Wu Y; Wang J; Qin J; Guo J; Gu Q; Zhang X; Ji T; Zhang Y; Xiong Z; Wang L; Wu X; Latham GJ; Jiang Y
BMC Pediatr; 2015 Jul; 15():77. PubMed ID: 26174701
[TBL] [Abstract][Full Text] [Related]
7. Molecular screening of intellectually disabled patients and those with premature ovarian failure for CGG repeat expansion at FMR1 locus: Implication of combined triplet repeat primed polymerase chain reaction and methylation-specific polymerase chain reaction analysis.
Muthuswamy S; Dean DD; Agarwal S
Neurol India; 2016; 64(6):1175-1179. PubMed ID: 27841182
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic testing in fragile X syndrome].
Sireteanu A; Rusu C
Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):968-71. PubMed ID: 17438909
[TBL] [Abstract][Full Text] [Related]
9. An effective strategy of using molecular testing to screen mentally retarded individuals for fragile X syndrome.
Tzeng CC; Lin SJ; Chen YJ; Kuo PL; Jong YJ; Tsai LP; Chen RM
Diagn Mol Pathol; 2001 Mar; 10(1):34-40. PubMed ID: 11277393
[TBL] [Abstract][Full Text] [Related]
10. Clinical Genetic Testing for Fragile X Syndrome by Polymerase Chain Reaction Amplification and Southern Blot Analyses.
Cai X; Arif M; Wan H; Kornreich R; Edelmann LJ
Methods Mol Biol; 2019; 1942():11-27. PubMed ID: 30900172
[TBL] [Abstract][Full Text] [Related]
11. Fragile X syndrome.
Saldarriaga W; Tassone F; González-Teshima LY; Forero-Forero JV; Ayala-Zapata S; Hagerman R
Colomb Med (Cali); 2014; 45(4):190-8. PubMed ID: 25767309
[TBL] [Abstract][Full Text] [Related]
12. Repeat expansion and methylation-sensitive triplet-primed polymerase chain reaction for fragile X mental retardation 1 gene screening in institutionalised intellectually disabled individuals.
Sihombing NRB; Cai S; Wong DPW; Guan M; Chong SS; Faradz SMH; Winarni TI
Singapore Med J; 2021 Mar; 62(3):143-148. PubMed ID: 31989181
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of Fragile-X Syndrome, 8p23.1 Deletion, and Balanced Translocation t(7;10)(p10;q24) in a Single Family.
Cortés H; Reyes-Rosales M; Rojas-Velasco AJ; García-Juárez B; Tapia-Guerrero YS; Arenas-Diaz S; Leyva-García N; Macías-Gallardo JJ; Carrillo-Mora P; Magaña JJ
Genet Test Mol Biomarkers; 2020 Aug; 24(8):527-531. PubMed ID: 32716213
[No Abstract] [Full Text] [Related]
14. Molecular analysis of fragile X syndrome (FXS) among Malaysian patients with developmental disability.
Ali EZ; Yakob Y; Md Desa N; Ishak T; Zakaria Z; Ngu LK; Keng WT
Malays J Pathol; 2017 Aug; 39(2):99-106. PubMed ID: 28866690
[TBL] [Abstract][Full Text] [Related]
15. Pilot fragile X screening in normal population of Taiwan.
Tzeng CC; Cho WC; Kuo PL; Chen RM
Diagn Mol Pathol; 1999 Sep; 8(3):152-6. PubMed ID: 10565687
[TBL] [Abstract][Full Text] [Related]
16. Standardization of capillary electrophoresis for diagnosis of fragile X syndrome in the Brazilian public health system.
Gigonzac MA; Teodoro LS; Minasi LB; Vieira TC; da Cruz AD
Electrophoresis; 2016 Dec; 37(23-24):3076-3078. PubMed ID: 27667322
[TBL] [Abstract][Full Text] [Related]
17. Establishment of FXS-A9 panel with a single human X chromosome from fragile X syndrome-associated individual.
Nakayama Y; Adachi K; Shioda N; Maeta S; Nanba E; Kugoh H
Exp Cell Res; 2021 Jan; 398(2):112419. PubMed ID: 33296661
[TBL] [Abstract][Full Text] [Related]
18. Fragile X syndrome: a review of clinical and molecular diagnoses.
Ciaccio C; Fontana L; Milani D; Tabano S; Miozzo M; Esposito S
Ital J Pediatr; 2017 Apr; 43(1):39. PubMed ID: 28420439
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic, carrier and prenatal genetic testing for fragile X syndrome and other FMR-1-related disorders in Johannesburg, South Africa: a 20-year review.
Essop FB; Krause A
S Afr Med J; 2013 Oct; 103(12 Suppl 1):994-8. PubMed ID: 24300646
[TBL] [Abstract][Full Text] [Related]
20. Simple molecular diagnostic method for fragile X syndrome in Egyptian patients: pilot study.
Meguid NA; Ismail MF; El-Mahdy RS; Barakat MA; El-Awady MK
Acta Biochim Pol; 2014; 61(2):259-63. PubMed ID: 24936518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
